| Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial LA Guay, P Musoke, T Fleming, D Bagenda, M Allen, C Nakabiito, ... The Lancet 354 (9181), 795-802, 1999 | 2378 | 1999 |
| Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the … JB Jackson, P Musoke, T Fleming, LA Guay, D Bagenda, M Allen, ... The Lancet 362 (9387), 859-868, 2003 | 700 | 2003 |
| A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006) P Musoke, LA Guay, D Bagenda, M Mirochnick, C Nakabiito, T Fleming, ... Aids 13 (4), 479-486, 1999 | 258 | 1999 |
| Patterns and predictors of self-medication in northern Uganda M Ocan, F Bwanga, GS Bbosa, D Bagenda, P Waako, J Ogwal-Okeng, ... PloS one 9 (3), e92323, 2014 | 214 | 2014 |
| Association of the quick sequential (sepsis-related) organ failure assessment (qSOFA) score with excess hospital mortality in adults with suspected infection in low-and middle … KE Rudd, CW Seymour, AR Aluisio, ME Augustin, DS Bagenda, A Beane, ... Jama 319 (21), 2202-2211, 2018 | 199 | 2018 |
| Growth failure as a prognostic indicator of mortality in pediatric HIV infection R Berhane, D Bagenda, L Marum, E Aceng, C Ndugwa, RJ Bosch, ... Pediatrics 100 (1), e7-e7, 1997 | 177 | 1997 |
| Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children D Bagenda, A Nassali, I Kalyesubula, B Sherman, D Drotar, MJ Boivin, ... Pediatrics 117 (3), 729-740, 2006 | 169 | 2006 |
| Estimating the net effect of HIV on child mortality in African populations affected by generalized HIV epidemics M Marston, B Zaba, JA Salomon, H Brahmbhatt, D Bagenda JAIDS Journal of Acquired Immune Deficiency Syndromes 38 (2), 219-227, 2005 | 117 | 2005 |
| Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children I Kalyesubula, P Musoke-Mudido, L Marum, D Bagenda, E Aceng, ... The Pediatric infectious disease journal 16 (9), 876-881, 1997 | 116 | 1997 |
| Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study PM Musoke, P Mudiope, LN Barlow-Mosha, P Ajuna, D Bagenda, ... BMC pediatrics 10, 1-11, 2010 | 109 | 2010 |
| Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: findings from two perinatal HIV prevention trials in Kampala, Uganda C Onyango-Makumbi, D Bagenda, A Mwatha, SB Omer, P Musoke, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 53 (1), 20-27, 2010 | 93 | 2010 |
| Validating population surveys for the measurement of HIV/STD prevention indicators E Konings, G Bantebya, M Caraël, D Bagenda, T Mertens Aids 9 (4), 375-382, 1995 | 93 | 1995 |
| Men at risk; a qualitative study on HIV risk, gender identity and violence among men who have sex with men who report high risk behavior in Kampala, Uganda R King, J Barker, S Nakayiwa, D Katuntu, G Lubwama, D Bagenda, ... PloS one 8 (12), e82937, 2013 | 82 | 2013 |
| Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer KM Islam, T Anggondowati, PE Deviany, JE Ryan, A Fetrick, D Bagenda, ... BMC cancer 19, 1-9, 2019 | 68 | 2019 |
| Noninferiority of a task-shifting HIV care and treatment model using peer counselors and nurses among Ugandan women initiated on ART: evidence from a randomized trial FM Kiweewa, D Wabwire, J Nakibuuka, M Mubiru, D Bagenda, P Musoke, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 63 (4), e125-e132, 2013 | 66 | 2013 |
| The good, the bad, and the unknown: quality of clinical laboratories in Kampala, Uganda AM Elbireer, JB Jackson, H Sendagire, A Opio, D Bagenda, TK Amukele PLoS One 8 (5), e64661, 2013 | 58 | 2013 |
| Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda LA Guay, P Musoke, DL Hom, C Nakabiito, D Bagenda, CV Fletcher, ... Aids 16 (10), 1391-1400, 2002 | 53 | 2002 |
| Vitamin-D deficiency impairs CD4+ T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: a longitudinal study AE Ezeamama, D Guwatudde, M Wang, D Bagenda, R Kyeyune, ... Clinical nutrition 35 (5), 1110-1117, 2016 | 49 | 2016 |
| Factors affecting disclosure of serostatus to children attending Jinja Hospital Paediatric HIV clinic, Uganda SM Namasopo-Oleja, D Bagenda, E Ekirapa-Kiracho African health sciences 15 (2), 344-351, 2015 | 49 | 2015 |
| Factors determining survival and retention among HIV-infected children and adolescents in a community home-based care and a facility-based family-centred approach in Kampala … W Massavon, L Barlow-Mosha, L Mugenyi, W McFarland, G Gray, ... International Scholarly Research Notices 2014, 2014 | 46 | 2014 |
